Suicide risk reduction in youths with attention-deficit/hyperactivity disorder prescribed methylphenidate: A Taiwan nationwide population-based cohort study
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) youths have increased suicide risk. Nevertheless, the beneficial effects of methylphenidate (MPH) on suicide attempt have received relatively little attention. AIMS: To investigate the MPH usage and the risk of suicide attempt among ADHD youths. METHODS: We identified 84,898 youths less than 18 years old with ADHD diagnosis between 1997 and 2013 from National Health Insurance, and examined whether MPH use affected suicide attempt risk using Cox proportional-hazards models. OUTCOME AND RESULTS: Among ADHD youths, reduction of suicide risk was found in patients prescribed 90-180days of MPH after adjusting for confounding factors (hazard ratio (HR): 0.41, 95% confidence interval (CI): 0.19-0.90) and a greater reduction in those prescribed more than 180days of MPH (HR: 0.28, 95% CI: 0.17-0.48). CONCLUSIONS AND IMPLICATIONS: We observed a 59% suicide attempt risk reduction among ADHD youths prescribed between 90 and 180days and a 72% risk reduction in those prescribed more than 180days of MPH. The protective benefit observed by the group prescribed MPH for longer duration underscores the importance of psychoeducation and compliance enhancement as part of ADHD management. Indication bias is identified as a limitation of this study, and future self-case control study to investigate the association between suicide attempt and ADHD medication is suggested. WHAT THIS PAPER ADDS: This nationwide population-based cohort study showed that among ADHD youths, reduction of suicide risk was observed in patients prescribed MPH for duration 90days and longer, underscoring the importance of appropriate ADHD pharmacotherapy and enhancing drug compliance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
Agerbo, E., Nordentoft, M., & Mortensen, P. B. (2002) · BMJ · doi:10.1136/bmj.325.7355.74 · Cited by 427
Brain-derived neurotrophic factor: role in depression and suicide
Dwivedi, Y. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s5700 · Cited by 355
Chang, Z., Lichtenstein, P., D’Onofrio, B. M., Sjölander, A., & Larsson, H. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4174 · Cited by 293
Fusar-Poli, P., Rubia, K., Rossi, G., Sartori, G., & Balottin, U. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11060940 · Cited by 260
Attention deficit hyperactivity disorder and suicide: a review of possible associations
James, A., Lai, F. H., & Dahl, C. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00384.x · Cited by 224
Suicide-Related Events in Patients Treated with Antiepileptic Drugs
Arana, A., Wentworth, C. E., Ayuso-Mateos, J. L., & Arellano, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909801 · Cited by 205
Chen, Q., Sjolander, A., Runeson, B., D'Onofrio, B. M., Lichtenstein, P., & Larsson, H. (2014) · BMJ · doi:10.1136/bmj.g3769 · Cited by 170
Dalsgaard, S., Leckman, J. F., Mortensen, P. B., Nielsen, H. S., & Simonsen, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00271-0 · Cited by 170
Relationship Between Antiepileptic Drugs and Suicide Attempts in Patients With Bipolar Disorder
Gibbons, R. D., Hur, K., Brown, C. H., & Mann, J. J. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.159 · Cited by 156
Meta-Analysis of Suicide-Related Behavior Events in Patients Treated With Atomoxetine
BANGS, M. E., TAUSCHER-WISNIEWSKI, S., POLZER, J., ZHANG, S., ACHARYA, N., DESAIAH, D., TRZEPACZ, P. T., & ALLEN, A. J. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815d88b2 · Cited by 152
Asherson, P., Chen, W., Craddock, B., & Taylor, E. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.026484 · Cited by 105
Amiri, A., Torabi Parizi, G., Kousha, M., Saadat, F., Modabbernia, M.-J., Najafi, K., & Atrkar Roushan, Z. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.07.018 · Cited by 58
Chou, T.-L., Chia, S., Shang, C.-Y., & Gau, S. S.-F. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.08.024 · Cited by 44
Banaschewski, T., Johnson, M., Lecendreux, M., Zuddas, A., Adeyi, B., Hodgkins, P., Squires, L. A., & Coghill, D. R. (2014) · CNS Drugs · doi:10.1007/s40263-014-0193-z · Cited by 41
Dalsgaard, S., Hansen, N., Mortensen, P. B., Damm, D., & Thomsen, P. H. (2001) · European Child & Adolescent Psychiatry · doi:10.1007/s007870170012 · Cited by 32
Chou, I.-C., Lin, C.-C., Sung, F.-C., & Kao, C.-H. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2014.05.006 · Cited by 22
Research works printed but not linked: 26
- Allely, 2014, The association of ADHD symptoms to self-harm behaviours: A systematic PRISMA review, BMC Psychiatry, 14, 133, 10.1186/1471-244X-14-133 · DOI · Paper page
- Bangs, 2014, Meta-analysis of suicide-related behavior or ideation in child, adolescent, and adult patients treated with atomoxetine, Journal of Child and Adolescent Psychopharmacology, 24, 426, 10.1089/cap.2014.0005 · DOI · Paper page
- Bridge, 2006, Adolescent suicide and suicidal behavior, Journal of Child Psychology and Psychiatry, 47, 372, 10.1111/j.1469-7610.2006.01615.x · DOI · Paper page
- Buitelaar, 2010, Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: A review of the potential benefits of long-acting stimulants, European Child and Adolescent Psychiatry, 19, 325, 10.1007/s00787-009-0056-1 · DOI · Paper page
- Chou, 2014, Attention-deficit-hyperactivity disorder increases risk of bone fracture: A population-based cohort study, Developmental Medicine & Child Neurology, 56, 1111, 10.1111/dmcn.12501 · DOI · Paper page
- Chronis-Tuscano, 2010, Very early predictors of adolescent depression and suicide attempts in children with attention-deficit/hyperactivity disorder, Archives of General Psychiatry, 67, 1044, 10.1001/archgenpsychiatry.2010.127 · DOI · Paper page
- Clemow, 2015, Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients, Journal of Psychopharmacology, 29, 1221, 10.1177/0269881115602489 · DOI · Paper page
- Faraone, 2007, Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion, Journal of Clinical Psychiatry, 68, 15
- Gajria, 2014, Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder—A systematic literature review, Neuropsychiatric Disease and Treatment, 10, 1543
- Gau, 2008, National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan, Journal of Clininical Psychiatry, 69, 131, 10.4088/JCP.v69n0118 · DOI · Paper page
- Gazer-Snitovsky, 2015, High familial correlation in methylphenidate response and side effect profile, Journal of Attention Disorders, 10.1177/1087054715580844 · DOI
- Golden, 2006, Nonepileptic uses of antiepileptic drugs in children and adolescents, Pediatric Neurology, 34, 421, 10.1016/j.pediatrneurol.2005.08.017 · DOI
- Hurtig, 2012, Suicidal and self-harm behaviour associated with adolescent attention deficit hyperactivity disorder—A study in the Northern Finland Birth Cohort 1986, Nordic Journal of Psychiatry, 66, 320, 10.3109/08039488.2011.644806 · DOI · Paper page
- Impey, 2012, Completed suicide, ideation and attempt in attention deficit hyperactivity disorder, Acta Psychiatrica Scandinavica, 125, 93, 10.1111/j.1600-0447.2011.01798.x · DOI · Paper page
- Landmark, 2009, Antiepileptic drugs in epilepsy and other disorders—A population-based study of prescriptions, Epilepsy Research, 87, 31, 10.1016/j.eplepsyres.2009.07.005 · DOI
- Lee, 2016, Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: A nationwide population-based study in Taiwan, Journal of Affective Disorders, 189, 110, 10.1016/j.jad.2015.09.015 · DOI
- Leon, 2012, Antiepileptic drugs for bipolar disorder and the risk of suicidal behavior: A 30-year observational study, The American Journal of Psychiatry, 169, 285, 10.1176/appi.ajp.2011.11060948 · DOI · Paper page
- Markowitz, 2001, Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder, Clinical Pharmacokinetics, 40, 753, 10.2165/00003088-200140100-00004 · DOI · Paper page
- Meszaros, 2017, Self-injury and externalizing pathology: A systematic literature review, BMC Psychiatry, 17, 160, 10.1186/s12888-017-1326-y · DOI
- Olesen, 2010, Antiepileptic drugs and risk of suicide: A nationwide study, Pharmacoepidemiology and Drug Safety, 19, 518, 10.1002/pds.1932 · DOI
- Paternite, 1999, Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes, Journal of Child and Adolescent Psychopharmacology, 9, 169, 10.1089/cap.1999.9.169 · DOI · Paper page
- Patorno, 2010, Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death, JAMA: The Journal of the American Medical Association, 303, 1401, 10.1001/jama.2010.410 · DOI · Paper page
- Søndergård, 2008, Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide, Bipolar Disorders, 10, 87, 10.1111/j.1399-5618.2008.00464.x · DOI · Paper page
- Savill, 2012, Child and Adolescent Psychiatry and Mental Health, 6
- Vijayakumar, 2005, Suicide and mental disorders in Asia, International Review of Psychiatry, 17, 109, 10.1080/09540260500074735 · DOI · Paper page
- Wilens, 2002, Attention deficit/hyperactivity disorder across the lifespan, Annual Review of Medicine, 53, 113, 10.1146/annurev.med.53.082901.103945 · DOI · Paper page
Cited by
Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.022 · Cited by 1,545
“After adjusting for relevant variables, it found a 60 % lower risk of suicide in those using methylphenidate for 3 months to half a year, and a 70 % reduction among those using methylphenidate for more than half a year (Liang et al., 2018b).”
A literature review and meta-analysis on the effects of ADHD medications on functional outcomes
Boland, H., DiSalvo, M., Fried, R., Woodworth, K. Y., Wilens, T., Faraone, S. V., & Biederman, J. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.01.006 · Cited by 240
Chang, Z., Ghirardi, L., Quinn, P. D., Asherson, P., D’Onofrio, B. M., & Larsson, H. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.009 · Cited by 175
“, injuries, suicide attempts) with duration of treatment defined as time-fixed variables (38, 61).”
Metadata
- Authors
- Liang, S. H.-Y., Yang, Y.-H., Kuo, T.-Y., Liao, Y.-T., Lin, T.-C., Lee, Y., McIntyre, R. S., Kelsen, B. A., Wang, T.-N., & Chen, V. C.-H.
- Venue
- Research in Developmental Disabilities
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 72
- Pages
- 96-105
- ISSN
- 0891-4222 (ISSN-L)
- OpenAlex
- W2767261087
- Cited by
- 58
- References
- 17
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Ministry of Science and Technology, Taiwan, ROC (102-2314-B-040-004-MY3)
- Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital, Taiwan, ROC (CMRPG6E0261)
- Chang Gung Memorial Hospital
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.